Looking to Breathe Life Into Array Scanner Market, Vidar Launches Its First System | GenomeWeb
When it comes to the microarray market, much of the emphasis is often on density, like the upcoming 1-million SNP whole-genome genotyping chips touted by Illumina and Affymetrix, or on emerging applications like the miRNA arrays marketed by Exiqon, Invitrogen, and CombiMatrix.
 
One frequently overlooked component of the marketplace, however, is the open-platform microarray scanner, and imaging company Vidar Systems hopes to capitalize on this by selling a newly developed system.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.